George Angelo Bertolucci

George Bertolucci practices at California Eye Institute in Fresno, California.

George Bertolucci's NPI, 1447267505, was assigned on August 2, 2006. George Bertolucci graduated from Creighton University School of Medicine - Omaha in 1986. George Bertolucci holds California license G60951.

George Bertolucci's primary practice is California Eye Institute, at 1360 E Herndon Ave, Fresno, CA 93720 in Fresno County. The practice phone is (559) 449-5000.

George Bertolucci's primary practice is California Eye Institute in Fresno, California. George Bertolucci is also affiliated with Saint Agnes Medical Center. Dmand AI also links George Bertolucci to 1 more hospital, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where George Bertolucci practices, 5 sites in all. Vendor and product names are available with a free account.

Ophthalmology is George Bertolucci's primary specialty in the NPI Registry, under taxonomy code 207W00000X. George Bertolucci is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has George Bertolucci's licenses on file in 3 states: California, Nevada and Arizona.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, glaucoma, glaucoma surgery and hypertensive retinopathy among the conditions George Bertolucci treats.

CMS data shows 34,513 Medicare services from George Bertolucci across 19 procedure codes in 2024, for 1,439 Medicare patients. Medicare paid $2,896,540 for them. Every service was in an office.

CMS counts 1,439 Medicare patients who saw George Bertolucci in 2024. The largest group is 75 to 84, with 625 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts George Bertolucci's median patient age at 75, with 55% women.

In 2024, George Bertolucci wrote 789 Medicare Part D claims for 229 patients. 56% of them were for generic drugs. CMS names the drug for 693 of them, across 11 drugs with 11 or more claims each, at $41,000 in total drug cost. In 2023, CMS named 840 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for George Bertolucci for performance year 2024, reported as part of a group. George Bertolucci accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 29 procedures of cataract surgery by George Bertolucci, more than 52% of the clinicians it reports for that procedure.

Dmand AI links George Bertolucci to 1 clinical trial.

CMS Open Payments shows 206 general payments to George Bertolucci from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 62% of the total. Alexion Pharmaceuticals, Inc. paid the most, $4,003. It also lists 13 research payments totaling $74,292 from 2019 to 2024.

Dmand AI lists 2 awards for George Bertolucci, most recently CMS Stage 1 EHR in 2013.

George Bertolucci graduated from Creighton University School of Medicine - Omaha in 1986. George Bertolucci is a member of AAO.

George Bertolucci is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.